Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The objective of this study was to evaluate and compare the bioavailability and therefore to assess the bioequivalence of two different formulations of sitagliptin/metformin extended release tablets after a single oral dose administration under fasting conditions.
Epistemonikos ID: 6646ff0d6e0a239117fb056fdfb41eebd92ae758
First added on: May 15, 2024